From in silico discovery to intracellular activity: Targeting JNK-protein interactions with small molecules

ACS Medicinal Chemistry Letters

Volumn 3, Issue 9, 2012, Pages 721-725

  Kaoud, Tamer S ^a   Yan, Chunli ^b   Mitra, Shreya ^c   Tseng, Chun Chia ^a   Jose, Jiney ^a   Taliaferro, Juliana M ^a   Tuohetahuntila, Maidina ^a   Devkota, Ashwini ^a   Sammons, Rachel ^a,b   Park, Jihyun ^a   Park, Heekwang ^d   Shi, Yue ^a,b   Hong, Jiyong ^d   Ren, Pengyu ^a,b   Dalby, Kevin N ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b The University of Texas at Austin   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d DUKE UNIVERSITY   (United States)

Author keywords

JNK; JNK JIP interaction; molecular docking and dynamics; non ATP competitive inhibitor; virtual screening

Indexed keywords

ACTIN; LIGNAN DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; P38 MITOGEN ACTIVATED PROTEIN KINASE ALPHA; PROTEIN C JUN; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG; ZUONIN A;

ARTICLE; CELL STRAIN HEK293; DRUG SCREENING; DRUG SELECTIVITY; DRUG TARGETING; ENZYME ASSAY; ENZYME INHIBITION; IC 50; MOLECULAR DOCKING; MOLECULAR DYNAMICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; VIRTUAL REALITY;

EID: 84866420052     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml300129b     Document Type: Article

References (24)

1. Barr, R. K.; Bogoyevitch, M. A. The c-Jun N-terminal protein kinase family of mitogen-activated protein kinases (JNK MAPKs) Int. J. Biochem. Cell B 2001, 33 (11) 1047-1063
2. Kyriakis, J. M.; Avruch, J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation Physiol. Rev. 2001, 81 (2) 807-869
3. Pearson, G.; Robinson, F.; Gibson, T. B.; Xu, B. E.; Karandikar, M.; Berman, K.; Cobb, M. H. Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions Endocr. Rev. 2001, 22 (2) 153-183
4. Manning, A. M.; Davis, R. J. Targeting JNK for therapeutic benefit: From JuNK to gold? Nat. Rev. Drug Discovery 2003, 2 (7) 554-565
5. Bogoyevitch, M. A. Therapeutic promise of JNK ATP-noncompetitive inhibitors Trends Mol. Med. 2005, 11 (5) 232-239
6. Siddiqui, M. A.; Reddy, P. A. Small molecule JNK (c-Jun N-terminal kinase) inhibitors J. Med. Chem. 2010, 53 (8) 3005-3012
7. Schnieders, M. J.; Kaoud, T. S.; Yan, C.; Dalby, K. N.; Ren, P. Computational Insights for the Discovery of Non-ATP Competitive Inhibitors of MAP Kinases Curr. Pharm. Des. 2012, 18, 1173-1185
8. Yasuda, J.; Whitmarsh, A. J.; Cavanagh, J.; Sharma, M.; Davis, R. J. The JIP group of mitogen-activated protein kinase scaffold proteins Mol. Cell. Biol. 1999, 19 (10) 7245-7254
9. Zhan, X.; Kaoud, T. S.; Dalby, K. N.; Gurevich, V. V. Nonvisual arrestins function as simple scaffolds assembling the MKK4-JNK3alpha2 signaling complex Biochemistry 2011, 50 (48) 10520-10529
10. Heo, J. S.; Kim, S. K.; Seo, C. I.; Kim, Y. K.; Sung, B. J.; Lee, H. S.; Lee, J. I.; Park, S. Y.; Kim, J. H.; Hwang, K. Y.; Hyun, Y. L.; Jeon, Y. H.; Ro, S.; Cho, J. M.; Lee, T. G.; Yang, C. H. Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125 EMBO J. 2004, 23 (11) 2185-2195
11. Kaoud, T. S.; Mitra, S.; Lee, S.; Taliaferro, J.; Cantrell, M.; Linse, K. D.; Van Den Berg, C. L.; Dalby, K. N. Development of JNK2-selective peptide inhibitors that inhibit breast cancer cell migration ACS Chem. Biol. 2011, 6 (6) 658-666
12. Mitra, S.; Lee, J. S.; Cantrell, M.; Van den Berg, C. L. c-Jun N-terminal kinase 2 (JNK2) enhances cell migration through epidermal growth factor substrate 8 (EPS8) J. Biol. Chem. 2011, 286 (17) 15287-15297
13. Stebbins, J. L.; De, S. K.; Machleidt, T.; Becattini, B.; Vazquez, J.; Kuntzen, C.; Chen, L. H.; Cellitti, J. F.; Riel-Mehan, M.; Emdadi, A.; Solinas, G.; Karin, M.; Pellecchia, M. Identification of a new JNK inhibitor targeting the JNK-JIP interaction site Proc. Natl. Acad. Sci. U.S.A. 2008, 105 (43) 16809-16813
14. De, S. K.; Chen, L. H.; Stebbins, J. L.; Machleidt, T.; Riel-Mehan, M.; Dahl, R.; Chen, V.; Yuan, H.; Barile, E.; Emdadi, A.; Murphy, R.; Pellecchia, M. Discovery of 2-(5-nitrothiazol-2-ylthio)benzo[d]thiazoles as novel c-Jun N-terminal kinase inhibitors Bioorg. Med. Chem. 2009, 17 (7) 2712-2717
15. De, S. K.; Stebbins, J. L.; Chen, L. H.; Riel-Mehan, M.; Machleidt, T.; Dahl, R.; Yuan, H.; Emdadi, A.; Barile, E.; Chen, V.; Murphy, R.; Pellecchia, M. Design, synthesis, and structure-activity relationship of substrate competitive, selective, and in vivo active triazole and thiadiazole inhibitors of the c-Jun N-terminal kinase J. Med. Chem. 2009, 52 (7) 1943-1952
16. De, S. K.; Chen, V.; Stebbins, J. L.; Chen, L. H.; Cellitti, J. F.; Machleidt, T.; Barile, E.; Riel-Mehan, M.; Dahl, R.; Yang, L.; Emdadi, A.; Murphy, R.; Pellecchia, M. Synthesis and optimization of thiadiazole derivatives as a novel class of substrate competitive c-Jun N-terminal kinase inhibitors Bioorg. Med. Chem. 2010, 18 (2) 590-596
17. Chen, T.; Kablaoui, N.; Little, J.; Timofeevski, S.; Tschantz, W. R.; Chen, P.; Feng, J.; Charlton, M.; Stanton, R.; Bauer, P. Identification of small-molecule inhibitors of the JIP-JNK interaction Biochem. J. 2009, 420 (2) 283-294
18. Comess, K. M.; Sun, C.; Abad-Zapatero, C.; Goedken, E. R.; Gum, R. J.; Borhani, D. W.; Argiriadi, M.; Groebe, D. R.; Jia, Y.; Clampit, J. E.; Haasch, D. L.; Smith, H. T.; Wang, S.; Song, D.; Coen, M. L.; Cloutier, T. E.; Tang, H.; Cheng, X.; Quinn, C.; Liu, B.; Xin, Z.; Liu, G.; Fry, E. H.; Stoll, V.; Ng, T. I.; Banach, D.; Marcotte, D.; Burns, D. J.; Calderwood, D. J.; Hajduk, P. J. Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases ACS Chem. Biol. 2011, 6 (3) 234-244
19. Voigt, J. H.; Bienfait, B.; Wang, S.; Nicklaus, M. C. Comparison of the NCI open database with seven large chemical structural databases J. Chem. Inf. Comput. Sci. 2001, 41 (3) 702-712
20. Fogolari, F.; Brigo, A.; Molinari, H. Protocol for MM/PBSA molecular dynamics simulations of proteins Biophys. J. 2003, 85 (1) 159-166
21. Halgren, T. A.; Nachbar, R. B. Merck molecular force field. IV. conformational energies and geometries for MMFF94 J. Comput. Chem. 1996, 17 (5-6) 587-615
22. Middelbeek, J.; Clark, K.; Venselaar, H.; Huynen, M. A.; van Leeuwen, F. N. The alpha-kinase family: An exceptional branch on the protein kinase tree Cell. Mol. Life Sci.: CMLS 2010, 67 (6) 875-890
23. Soares, K. M.; Blackmon, N.; Shun, T. Y.; Shinde, S. N.; Takyi, H. K.; Wipf, P.; Lazo, J. S.; Johnston, P. A. Profiling the NIH Small Molecule Repository for compounds that generate H2O2 by redox cycling in reducing environments Assay Drug Dev. Technol. 2010, 8 (2) 152-174
24. Repici, M.; Mare, L.; Colombo, A.; Ploia, C.; Sclip, A.; Bonny, C.; Nicod, P.; Salmona, M.; Borsello, T. c-Jun N-terminal kinase binding domain-dependent phosphorylation of mitogen-activated protein kinase kinase 4 and mitogen-activated protein kinase kinase 7 and balancing cross-talk between c-Jun N-terminal kinase and extracellular signal-regulated kinase pathways in cortical neurons Neuroscience 2009, 159 (1) 94-103